Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo

Hong Wang, Jeffrey L. Garvin, Martin A. D'Ambrosio, J R Falck, Pablo Leung, Ruisheng Liu, Yilin Ren, Oscar A. Carretero

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Tubuloglomerular feedback (TGF) is a renal autoregulatory mechanism that constricts the afferent arteriole in response to increases in distal NaCl. Heme oxygenases (HO-1 and HO-2) release carbon monoxide (CO) and biliverdin, which may help control renal function. We showed in vitro that HO products inhibit TGF; however, we do not know whether this also occurs in vivo or the mechanism(s) involved. We hypothesized that in vivo HO-1 and HO-2 in the nephron inhibit TGF via release of CO and biliverdin. We first performed laser capture microdissection followed by real-time PCR and found that both HO-1 and HO-2 are expressed in the macula densa. We next performed micropuncture experiments in vivo on individual rat nephrons, adding different compounds to the perfusate, and found that an HO inhibitor, stannous mesoporphyrin (SnMP), potentiated TGF (P < 0.05, SnMP vs. control). The CO-releasing molecule (CORM)-3 partially inhibited TGF at 50 (μmol/l (P < 0.01, CORM-3 vs. control) and blocked it completely at higher doses. A soluble guanylyl cyclase (sGC) inhibitor, LY83583, blocked the inhibitory effect of CORM-3 on TGF. Biliverdin also partially inhibited TGF (P < 0.01, biliverdin vs. control), most likely attributable to decreased superoxide (O 2 -) because biliverdin was rendered ineffective by tempol, a O 2 - dismutase mimetic. We concluded that HO-1 and HO-2 in the nephron inhibit TGF by releasing CO and biliverdin. The inhibitory effect of CO on TGF is mediated by the sGC/cGMP signaling pathway, whereas biliverdin probably acts by reducing O 2 -.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume300
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Heme Oxygenase (Decyclizing)
Biliverdine
Carbon Monoxide
Nephrons
6-anilino-5,8-quinolinedione
Laser Capture Microdissection
Kidney
Heme Oxygenase-1
Arterioles
Punctures
Superoxides
Real-Time Polymerase Chain Reaction

Keywords

  • Afferent arteriole
  • Biliverdin
  • Carbon monoxide
  • Stop-flow pressure

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo. / Wang, Hong; Garvin, Jeffrey L.; D'Ambrosio, Martin A.; Falck, J R; Leung, Pablo; Liu, Ruisheng; Ren, Yilin; Carretero, Oscar A.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 300, No. 4, 04.2011.

Research output: Contribution to journalArticle

Wang, Hong ; Garvin, Jeffrey L. ; D'Ambrosio, Martin A. ; Falck, J R ; Leung, Pablo ; Liu, Ruisheng ; Ren, Yilin ; Carretero, Oscar A. / Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo. In: American Journal of Physiology - Heart and Circulatory Physiology. 2011 ; Vol. 300, No. 4.
@article{33b0f3f7fa24413ab7d9905e1f7d03f7,
title = "Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo",
abstract = "Tubuloglomerular feedback (TGF) is a renal autoregulatory mechanism that constricts the afferent arteriole in response to increases in distal NaCl. Heme oxygenases (HO-1 and HO-2) release carbon monoxide (CO) and biliverdin, which may help control renal function. We showed in vitro that HO products inhibit TGF; however, we do not know whether this also occurs in vivo or the mechanism(s) involved. We hypothesized that in vivo HO-1 and HO-2 in the nephron inhibit TGF via release of CO and biliverdin. We first performed laser capture microdissection followed by real-time PCR and found that both HO-1 and HO-2 are expressed in the macula densa. We next performed micropuncture experiments in vivo on individual rat nephrons, adding different compounds to the perfusate, and found that an HO inhibitor, stannous mesoporphyrin (SnMP), potentiated TGF (P < 0.05, SnMP vs. control). The CO-releasing molecule (CORM)-3 partially inhibited TGF at 50 (μmol/l (P < 0.01, CORM-3 vs. control) and blocked it completely at higher doses. A soluble guanylyl cyclase (sGC) inhibitor, LY83583, blocked the inhibitory effect of CORM-3 on TGF. Biliverdin also partially inhibited TGF (P < 0.01, biliverdin vs. control), most likely attributable to decreased superoxide (O 2 -) because biliverdin was rendered ineffective by tempol, a O 2 - dismutase mimetic. We concluded that HO-1 and HO-2 in the nephron inhibit TGF by releasing CO and biliverdin. The inhibitory effect of CO on TGF is mediated by the sGC/cGMP signaling pathway, whereas biliverdin probably acts by reducing O 2 -.",
keywords = "Afferent arteriole, Biliverdin, Carbon monoxide, Stop-flow pressure",
author = "Hong Wang and Garvin, {Jeffrey L.} and D'Ambrosio, {Martin A.} and Falck, {J R} and Pablo Leung and Ruisheng Liu and Yilin Ren and Carretero, {Oscar A.}",
year = "2011",
month = "4",
doi = "10.1152/ajpheart.01118.2010",
language = "English (US)",
volume = "300",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo

AU - Wang, Hong

AU - Garvin, Jeffrey L.

AU - D'Ambrosio, Martin A.

AU - Falck, J R

AU - Leung, Pablo

AU - Liu, Ruisheng

AU - Ren, Yilin

AU - Carretero, Oscar A.

PY - 2011/4

Y1 - 2011/4

N2 - Tubuloglomerular feedback (TGF) is a renal autoregulatory mechanism that constricts the afferent arteriole in response to increases in distal NaCl. Heme oxygenases (HO-1 and HO-2) release carbon monoxide (CO) and biliverdin, which may help control renal function. We showed in vitro that HO products inhibit TGF; however, we do not know whether this also occurs in vivo or the mechanism(s) involved. We hypothesized that in vivo HO-1 and HO-2 in the nephron inhibit TGF via release of CO and biliverdin. We first performed laser capture microdissection followed by real-time PCR and found that both HO-1 and HO-2 are expressed in the macula densa. We next performed micropuncture experiments in vivo on individual rat nephrons, adding different compounds to the perfusate, and found that an HO inhibitor, stannous mesoporphyrin (SnMP), potentiated TGF (P < 0.05, SnMP vs. control). The CO-releasing molecule (CORM)-3 partially inhibited TGF at 50 (μmol/l (P < 0.01, CORM-3 vs. control) and blocked it completely at higher doses. A soluble guanylyl cyclase (sGC) inhibitor, LY83583, blocked the inhibitory effect of CORM-3 on TGF. Biliverdin also partially inhibited TGF (P < 0.01, biliverdin vs. control), most likely attributable to decreased superoxide (O 2 -) because biliverdin was rendered ineffective by tempol, a O 2 - dismutase mimetic. We concluded that HO-1 and HO-2 in the nephron inhibit TGF by releasing CO and biliverdin. The inhibitory effect of CO on TGF is mediated by the sGC/cGMP signaling pathway, whereas biliverdin probably acts by reducing O 2 -.

AB - Tubuloglomerular feedback (TGF) is a renal autoregulatory mechanism that constricts the afferent arteriole in response to increases in distal NaCl. Heme oxygenases (HO-1 and HO-2) release carbon monoxide (CO) and biliverdin, which may help control renal function. We showed in vitro that HO products inhibit TGF; however, we do not know whether this also occurs in vivo or the mechanism(s) involved. We hypothesized that in vivo HO-1 and HO-2 in the nephron inhibit TGF via release of CO and biliverdin. We first performed laser capture microdissection followed by real-time PCR and found that both HO-1 and HO-2 are expressed in the macula densa. We next performed micropuncture experiments in vivo on individual rat nephrons, adding different compounds to the perfusate, and found that an HO inhibitor, stannous mesoporphyrin (SnMP), potentiated TGF (P < 0.05, SnMP vs. control). The CO-releasing molecule (CORM)-3 partially inhibited TGF at 50 (μmol/l (P < 0.01, CORM-3 vs. control) and blocked it completely at higher doses. A soluble guanylyl cyclase (sGC) inhibitor, LY83583, blocked the inhibitory effect of CORM-3 on TGF. Biliverdin also partially inhibited TGF (P < 0.01, biliverdin vs. control), most likely attributable to decreased superoxide (O 2 -) because biliverdin was rendered ineffective by tempol, a O 2 - dismutase mimetic. We concluded that HO-1 and HO-2 in the nephron inhibit TGF by releasing CO and biliverdin. The inhibitory effect of CO on TGF is mediated by the sGC/cGMP signaling pathway, whereas biliverdin probably acts by reducing O 2 -.

KW - Afferent arteriole

KW - Biliverdin

KW - Carbon monoxide

KW - Stop-flow pressure

UR - http://www.scopus.com/inward/record.url?scp=79955066278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955066278&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.01118.2010

DO - 10.1152/ajpheart.01118.2010

M3 - Article

VL - 300

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4

ER -